Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Department of Endocrine and Metabolic Diseases, The First People's Hospital of Hefei, Anhui Medical University, Hefei, China.
Brain Behav. 2019 Sep;9(9):e01372. doi: 10.1002/brb3.1372. Epub 2019 Aug 6.
To identify deletions, duplications, and point mutations in 55 previously reported genes associated with Parkinson's disease (PD) and certain genes associated with tremor, spinocerebellar ataxia, and dystonia in a Han Chinese pedigree with early-onset Parkinson's disease (EOPD).
Clinical examinations and genomic analyses were performed on six subjects belonging to three generations of a Han Chinese family. Target region capture and high-throughput sequencing were used to screen these genes associated with PD, tremor, spinocerebellar ataxia, and dystonia. The multiplex ligation-dependent probe amplification (MLPA) method was applied to detect rearrangements in PARK2 exons. Direct Sanger sequencing of samples from all subjects further verified the detected abnormal PRKRA, SPTBN2, and ATXN2 gene fragments.
Two family members were diagnosed with PD based on the clinical manifestations, imaging analyses. PARK2 gene heterozygous deletion of exon 3 and heterozygous duplication of exon 6 were identified in them (II-3 and 4). A single heterozygous deletion of exon 3 in PARK2 was detected in II-5 and III-10. A single duplication of exon 6 in PARK2 was detected in I1. Both the heterozygous mutation c.2834G>A (p. R945H) in exon 16 and the heterozygous mutation c.1924 C>T (p. R642W) in exon 14 of the SPTBN2 gene were identified in II-3, II-4, and III-10. The heterozygous mutation c.2989 C>T (p. R997X) in exon 24 of the ATXN2 gene was detected in II-4 and II-5, and the heterozygous mutation c.170 C>A (p. S57Y) in exon 2 of the PRKRA gene was detected in II-3, II-4, and III-10. Other mutations in some genes associated with PD, tremor, spinocerebellar ataxia, and dystonia were not detected.
Novel compound heterozygous mutations were identified in a Han Chinese pedigree and might represent a cause of EOPD.
在一个早发性帕金森病(EOPD)的汉族家系中,鉴定与帕金森病(PD)相关的 55 个先前报道的基因以及与震颤、脊髓小脑共济失调和肌张力障碍相关的某些基因中的缺失、重复和点突变。
对属于三代汉族家系的 6 名个体进行临床检查和基因组分析。使用靶向区域捕获和高通量测序筛选与 PD、震颤、脊髓小脑共济失调和肌张力障碍相关的这些基因。应用多重连接依赖性探针扩增(MLPA)方法检测 PARK2 外显子的重排。对所有受试者的样本进行直接 Sanger 测序,进一步验证了所检测到的异常 PRKRA、SPTBN2 和 ATXN2 基因片段。
根据临床表现和影像学分析,两名家族成员被诊断为 PD。在他们(II-3 和 4)中发现 PARK2 基因外显子 3 的杂合性缺失和外显子 6 的杂合性重复。PARK2 外显子 3 的单个杂合性缺失在 II-5 和 III-10 中被检测到。在 I1 中检测到 PARK2 外显子 6 的单个重复。在 II-3、II-4 和 III-10 中发现 SPTBN2 基因外显子 16 的杂合突变 c.2834G>A(p.R945H)和外显子 14 的杂合突变 c.1924 C>T(p.R642W)。在 II-4 和 II-5 中检测到 ATXN2 基因外显子 24 的杂合突变 c.2989 C>T(p.R997X),在 II-3、II-4 和 III-10 中检测到 PRKRA 基因外显子 2 的杂合突变 c.170 C>A(p.S57Y)。未检测到一些与 PD、震颤、脊髓小脑共济失调和肌张力障碍相关的基因的其他突变。
在一个汉族家系中发现了新的复合杂合突变,可能是 EOPD 的病因。